Faviblu 200 mg Tablet

Faviblu 200 mg Tablet contains Favipiravir (200mg). Prescription required.

Treatment of mild to moderate COVID-19 infection in adults when prescribed by a doctor; may be used for other susceptible viral infections as per specialist advice.

Favipiravir is an antiviral that is converted in the body to an active form which inhibits viral RNA-dependent RNA polymerase. This blocks viral RNA replication and reduces viral multiplication.

Take by mouth exactly as prescribed. Swallow tablet whole with water; can be taken with or without food. Follow the full course and dosing schedule (often involves a higher loading dose on day 1 followed by maintenance doses) as advised by the doctor.

Nausea,diarrhoea,abdominal pain,increased uric acid (hyperuricaemia),raised liver enzymes (ALT/AST),headache,dizziness

Prescription-only antiviral; use only under medical supervision. Contraindicated in pregnancy and not recommended during breastfeeding due to risk of harm to the baby; effective contraception required during treatment and for a period after completion as advised by doctor. Use with caution in liver disease, kidney disease, gout/hyperuricaemia; monitor liver function and uric acid. Not a substitute for vaccination; seek urgent care if breathing worsens.

Pyrazinamide (may increase uric acid),theophylline (may increase levels),repaglinide (may increase levels/risk of hypoglycaemia); potential interactions with other hepatotoxic drugs—inform doctor about all medicines and supplements.

Store below 25°C in a cool, dry place. Protect from light and moisture. Keep out of reach of children.

Fabiflu 200 Tablet,Glenmark Favipiravir 200 mg Tablet (FabiFlu),Favivir 200 Tablet,Favipir 200 Tablet,Favipira 200 Tablet